Company
Insulet Corporation
Headquarters: Acton, MA, United States
Employees: 2,300
CEO: Ms. Shacey Petrovic
Market Cap
$19.88 Billion
USD as of Jan. 1, 2023
Insulet Corporation Categories
United States
languages
Healthcare
languages
Medical Devices
United States Healthcare
United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
|
Abbott
|
$191.43 B |
Medtronic
|
$103.38 B |
|
Stryker Corporation
|
$92.52 B |
|
Boston Scientific Corporation
|
$65.90 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
|
$56.23 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Stocks & Indices
Insulet Corporation has the following listings and related stock indices.
Stock: NASDAQ: PODD
Stock: FSX: GOV